Search
for
Sort by
Research 751–780 of 1000+
- Alfatradiol (0,025 %) - Eine wirksame und sichere Therapieoption zur Behandlung der androgenetischen Alopezie bei Frauen und Männern
- Split-scalp pilot study to evaluate effectiveness of Minoxidil 0,5% MMP® versus Topical Minoxidil 5% in the treatment of Female Pattern Hair Loss
- Finasteride 0,25 % solution topique : un nouveau traitement de l’alopécie androgénétique
- Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalis
- Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: A randomized, double-blind, placebo-controlled, phase III study
- A novel finasteride 0.25% topical solution for androgenetic alopecia: pharmacokinetics and effects on plasma androgen levels in healthy male volunteers
- Effect of dutasteride 0.5 mg/d in men with androgenetic alopecia recalcitrant to finasteride
- The Efficacy and Safety of 17α-Estradiol (Ell-Cranell® alpha 0.025%) Solution on Female Pattern Hair Loss: Single Center, Open-Label, Non-Comparative, Phase IV Study
- Latanoprostene bunod ophthalmic solution 0.024% in the treatment of open-angle glaucoma: design, development, and place in therapy
- Intradermal injections with 0.5% minoxidil for the treatment of female androgenetic alopecia: A randomized, placebo‐controlled trial
- Efficacy of Topical Finasteride 0.5% vs 17α-Estradiol 0.05% in the Treatment of Postmenopausal Female Pattern Hair Loss: A Retrospective, Single-Blind Study of 119 Patients
- The effect of latanoprost 0.005% solution in the management of scalp alopecia areata, a randomized double‐blind placebo‐controlled trial
- The prescribing cascade 3.0: a case for recreational drugs in HIV
- From industry 4.0 to lab 4.0
- Efficacy of topical tacrolimus 0.1% and clobetasol propionate 0.05% in the treatment of alopecia areata
- Bimatoprost solution 0·03% topical application to the eyelid margin for the treatment of eyelash hypotrichosis
- Efficacy of 0.1% adapalene in a non-inflammatory Kyoto Rhino Rat acne model
- Commentary on Micropunch (0.8 mm or Less in Diameter) Hair Transplantation
- Dermal safety comparison of 0.05% desonide cream and 1.0% hydrocortisone cream
- The Efectiveness of 0.03% Bimatoprost Solution Vs Minoxidil 5% in Androgenic Alopecia
- Topical finasteride 0.25% in HPCH spray for androgenetic alopecia: a single-center retrospective study
- Efficacy of Topical Finasteride 0.25% With Minoxidil 5% Versus Topical Minoxidil 5% Alone in Treatment of Male Pattern Androgenic Alopecia
- Topical Bimatoprost (0.03%) Versus Topical Mometasone Furoate (0.1%) in Treatment of Alopecia Areata
- Microneedling Plus Clobetasol Propionate 0.05% Cream versus Clobetasol Propionate 0.05% Cream Alone in the Treatment of Alopecia Areata
- Eruptive vellus hair cyst: Treatment with topical tretinoin 0.025% cream
- El teorema del 0,7 o el otro teorema de Pitágoras
- Outcome of Dutasteride 0.5mg in Androgenic Alopecia
- Effects of a novel finasteride 0.25% topical solution on scalp and serum dihydrotestosterone in healthy men with androgenetic alopecia
- Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara®) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III trial
- Topical niacinamide 4% and desonide 0.05% for treatment of axillary hyperpigmentation: a randomized, double-blind, placebo-controlled study